Clinical information
The clinical information of all the thirty-two T2DM patients participating in this study, from pre- and post-treatment visits with GLP-1R agonists are provided in the Table 1. The mean age for the patients at first sample collection was 63.7 ± 7.25 years and 56.3% of them were females. As depicted in the Table 1, no statistically significant difference between the clinical levels of Hemoglobin A1C (HbA1C), body weight, body mass index (BMI), systolic and diastolic blood pressure (SBP/DBP), eGFR, albuminuria to creatinine ratio and urinary creatinine was observed after the treatment with GLP-1R agonists.